Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $138.42M | $310.75M | $418.31M | $114.42M |
| Net Income | -$159.38M | -$57.17M | -$64.93M | -$174.07M |
| EPS Diluted | -$0.68 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.31 |
| -$0.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.